Asthma — Allogeneic Human Cells (hMSC) Via Intravenous Delivery in Patients With Mild Asthma
Citation(s)
A Phase I, Trial to Evaluate the Safety, Tolerability, and Potential Efficacy of Allogeneic Human Mesenchymal Stem Cell Infusion in Patients With Mild Asthma